<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02554331</url>
  </required_header>
  <id_info>
    <org_study_id>9183</org_study_id>
    <nct_id>NCT02554331</nct_id>
  </id_info>
  <brief_title>Gait and REM Sleep Behavior Disorder</brief_title>
  <acronym>RBD-M2H</acronym>
  <official_title>Recherche et Mesure d'Anomalies précoces de la Marche au Cours Des Troubles du Comportement en Sommeil Paradoxal Idiopathiques</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Université Montpellier</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Many people with idiopathic rapid eye movement (REM) sleep behavior disorder (RBD) have an
      underlying synucleinopathy, the most common of which are Parkinson's disease (PD) and Lewy
      body disease. Identifying additional abnormal clinical features may help in identifying those
      at greater risk of evolving to a more severe syndrome. Because gait disorders are common in
      the synucleinopathies, early abnormalities in gait in those with RBD could help in
      identifying those at increased risk of developing overt parkinsonism and/or cognitive
      impairment.

      The investigators aim to identify subtle gait abnormalities in idiopathic RBD and to identify
      sensitive and early biomarkers:

        1. to detect subtle gait disorders in pre-symptomatic stage of synucleinopathy and

        2. to track their evolution in the parallel with the disease progression.

      Main objective: In comparison with age and gender matched-controls, to identify in patients
      with RBD a larger reduction of gait velocity (and other abnormalities of spatio-temporal
      characteristics of gait) between a single (gait) and a dual-task (gait+cognitive task).

      Secondary objective:

        1. In comparison with age and gender matched-PD patients, to identify in patients with RBD
           a smaller reduction of gait velocity (and other abnormalities of spatio-temporal
           characteristics of gait) between a single (gait) and a dual-task (gait+cognitive task).

        2. In patients with RBD to identify correlations between the spatio-temporal
           characteristics modifications of gait between a single (gait) and a dual-task
           (gait+cognitive task) and the percentage of REM without atonia - the dopamine
           transporter (DAT) density using FP-CIT single-photon emission computed tomography; the
           reduction of the olfactory discrimination and thresholds.

        3. In patients with RBD to track the spatio-temporal characteristics evolution of gait over
           time (every 6 months for 2 years)
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>gait velocity</measure>
    <time_frame>Month 24</time_frame>
    <description>gait speed difference between single and dual tasks</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>spatio-temporal gait characteristics</measure>
    <time_frame>Month 24</time_frame>
    <description>oscillation phase duration difference between single and dual tasks</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">63</enrollment>
  <condition>Parkinson's Disease</condition>
  <condition>REM Sleep Behavior Disorder</condition>
  <arm_group>
    <arm_group_label>Patients RBD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients RBD subject to FP-CIT single-photon emission computed tomography and Neuropsychological evaluation and Gait recording with sensors</description>
  </arm_group>
  <arm_group>
    <arm_group_label>controls healthy volunteers</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>controls healthy volunteers subject to Neuropsychological evaluation and Gait recording with sensors</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>FP-CIT single-photon emission computed tomography</intervention_name>
    <description>FP-CIT radiolabeled is used as a surrogate marker to examine the integrity of the dopaminergic nigrostriatal neurons.</description>
    <arm_group_label>Patients RBD</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>neuropsychological evaluation</intervention_name>
    <description>Assessment of:
overall cognitive function
executive functions
visuospatial functions
Nonverbal memory
verbal memory
Evaluation of hearing ability of time perception and sensorimotor synchronization from selected tasks the Battery of assessment of auditory sensorimotor and timing abilities
Beck Depression Inventory</description>
    <arm_group_label>Patients RBD</arm_group_label>
    <arm_group_label>controls healthy volunteers</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Gait recording with sensors</intervention_name>
    <description>Gait recording with sensors</description>
    <arm_group_label>Patients RBD</arm_group_label>
    <arm_group_label>controls healthy volunteers</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Specific inclusion criteria for RBD patients - to reach the diagnosis criteria of RBD
             (International Classification of Sleep Disorders 2)

          -  Specific inclusion criteria for PD patients - to reach the diagnosis criteria of
             idiopathic PD (Queen Square Brain Bank) - Hoehn Yahr score ≤ 2

        Exclusion Criteria:

          -  Specific exclusion criteria for RBD patients - diagnosis of PD - other pathology
             associated to RBD diagnosis - presence of antiparkinsonism medication

          -  Specific exclusion criteria for PD patients - clinical signs of parkinsonian syndrome-
             Mini Mental State Examination &lt; 24/30- gait disorder clinically observable

          -  Specific exclusion criteria for controls - neurological disease- gait disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Valérie Cochen De Cock, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Valérie Cochen De Cock, MD</last_name>
    <phone>06 09 04 35 05</phone>
    <email>valerie.cochen@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University hospital</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valérie Cochen De Cock, MD</last_name>
      <phone>06 09 04 35 05</phone>
      <email>valerie.cochen@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 6, 2015</study_first_submitted>
  <study_first_submitted_qc>September 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 18, 2015</study_first_posted>
  <last_update_submitted>September 17, 2015</last_update_submitted>
  <last_update_submitted_qc>September 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 18, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Gait</keyword>
  <keyword>REM sleep behavior disorder</keyword>
  <keyword>Parkinson's disease</keyword>
  <keyword>Follow-up</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
    <mesh_term>Mental Disorders</mesh_term>
    <mesh_term>REM Sleep Behavior Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

